Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

This new catheter-based device for lymphatic drainage showed early potential to be an effective treatment option for acute decompensated heart failure.

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic. 

The company's Seismiq platform has already gained FDA approval for treating PAD. This new analysis highlights its potential to treat calcified coronary lesions during PCI procedures.

The new device from Arizona-based Corvention was built to withstand the extreme pressures associated with treating severely calcified valves. 

The American Society of Nuclear Cardiology visited Capitol Hill to advocate for a variety of issues. Cardiovascular Business spoke to the group's president to learn more.

Litt, a leading name in the fields of radiology and cardiology, has been with the journal since it was first launched in 2019. 

Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial. 

The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.

Pulnovo Medical, a global medtech company, plans on using the funds for clinical development, regulatory submissions, commercialization and much more. 

Food and Drug Administration Commissioner Marty Makary is about to become a former FDA chief. The departure comes as no surprise since President Donald Trump OK’d a plan to fire him last week. 

The former proprietor of a pharmacy in New Jersey was caught billing federal insurance for prescriptions of the antibiotic Dificid at $4,000 a pop, despite providers never ordering the pills. He pleaded guilty to charges of healthcare fraud conspiracy in November 2025.